Unknown

Dataset Information

0

Diagnostic and Prognostic Validity of Proadrenomedullin among Neonates with Sepsis in Tertiary Care Hospitals of Southern India.


ABSTRACT:

Introduction

To evaluate Proadrenomedullin (Pro-ADM) as the diagnostic and prognostic marker in neonatal sepsis.

Materials and methods

In this cross-sectional study, Pro-ADM levels were estimated in 54 neonates with clinical sepsis and positive sepsis screen (cases) and 54 controls without clinical sepsis. Repeat Pro-ADM levels were estimated after 72 hours in cases. Pro-ADM levels were compared with the clinical outcome.

Results and discussion

Median Pro-ADM levels in cases were 31.8 (IQR: 27.8-39.4) pmol/ml which was significantly higher than controls 5.1 (IQR; 3.1-7.7) pmol/ml. From the constructed ROC curve, a value of 14.5 pmol/ml was taken as the cut-off for sepsis. Pro-ADM had 100% sensitivity, specificity, and positive predictive values (PPV) in detecting sepsis at 14.5 pmol/ml. Among cases, a decrease in Pro-ADM level by 10 pmol/ml was associated with 99% survival. Pro-ADM value of 35 pmol/ml had 100% specificity and PPV in predicting mortality.

Conclusion

Pro-ADM can be used as a single biomarker for detecting neonatal sepsis, predicting clinical outcome and prognosis.

SUBMITTER: Kannan R 

PROVIDER: S-EPMC6092974 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC4843258 | biostudies-literature
| S-EPMC8167801 | biostudies-literature
| S-EPMC3901785 | biostudies-literature
| S-EPMC9122554 | biostudies-literature
| S-EPMC6257976 | biostudies-literature
| S-EPMC6023165 | biostudies-literature
| S-EPMC6283678 | biostudies-literature
| S-EPMC4879793 | biostudies-literature
| S-EPMC9551323 | biostudies-literature
| S-EPMC5525480 | biostudies-other